Repurposing the diuretic benzamil as an anti-osteosarcoma agent that acts by suppressing integrin/FAK/STAT3 signalling and compromising mitochondrial function

Meng‐Chieh Lin(Taipei Medical University), Bor‐Chyuan Su(Taipei Medical University)
Bone and Joint Research
April 4, 2024
Cited by 6


Related Papers